Finance

Lists
Why is 688073 down 2,55%?
Dive Deeper
688073:SHA
Bide Pharmatech Co Ltd
60,01 CNY
-2,55%
(-1,57) 1D
16 ოქტ, 15:00:02 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688073...
Open
62,98 CNY
High
66,48 CNY
Low
59,09 CNY
Mkt. cap
5,99 მლრდ.
Avg. vol.
4,67 მლნ.
Volume
5,58 მლნ.
Dividend
1,93%
Quarterly dividend
0,29 CNY
Ex-dividend date
10 ივნ. 2026
P/E ratio
28,45
52-wk high
88,88 CNY
52-wk low
43,21 CNY
EPS
2,11 CNY
No. of employees
734
Open
62,98 CNY
High
66,48 CNY
Low
59,09 CNY
Mkt. cap
5,99 მლრდ.
Avg. vol.
4,67 მლნ.
Volume
5,58 მლნ.
Dividend
1,93%
Quarterly dividend
0,29 CNY
Ex-dividend date
10 ივნ. 2026
P/E ratio
28,45
52-wk high
88,88 CNY
52-wk low
43,21 CNY
EPS
2,11 CNY
No. of employees
734
News stories
From web sources and news partners
The Daily News | Texas' Oldest Newspaper
The Daily News | Texas' Oldest Newspaper
·
49 წუთის წინ
Traders work on the floor of the NYSE in New York
The National Law Review
The National Law Review
·
20 წუთის წინ
Kaplan Fox Continues to Remind Honeywell Aerospace Inc. (NASDAQ
About Bide Pharmatech Co Ltd
CEO-
Employees734
Founded27 აპრ. 2007
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
351,58 მლნ.
344,70 მლნ.
323,28 მლნ.
359,56 მლნ.
Cost of goods sold
177,36 მლნ.
229,41 მლნ.
165,25 მლნ.
194,66 მლნ.
Cost of revenue
177,36 მლნ.
229,41 მლნ.
165,25 მლნ.
194,66 მლნ.
Research and development expenses
20,44 მლნ.
13,41 მლნ.
14,99 მლნ.
13,27 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
69,10 მლნ.
85,46 მლნ.
68,86 მლნ.
71,92 მლნ.
Operating expense
78,83 მლნ.
110,37 მლნ.
81,39 მლნ.
94,89 მლნ.
Total operating expenses
256,19 მლნ.
339,78 მლნ.
246,63 მლნ.
289,55 მლნ.
Operating income
95,39 მლნ.
4,92 მლნ.
76,64 მლნ.
70,01 მლნ.
Other non operating income
-8,48 მლნ.
7,57 მლნ.
-15,67 მლნ.
13,87 მლნ.
EBT including unusual items
58,72 მლნ.
35,86 მლნ.
61,38 მლნ.
75,58 მლნ.
EBT excluding unusual items
92,94 მლნ.
-1,67 მლნ.
64,07 მლნ.
62,13 მლნ.
Income tax expense
12,39 მლნ.
3,86 მლნ.
14,55 მლნ.
19,10 მლნ.
Effective tax rate
21,11%
10,75%
23,71%
25,27%
Other operating expenses
-9,25 მლნ.
11,14 მლნ.
-3,21 მლნ.
7,06 მლნ.
Net income
46,33 მლნ.
32,01 მლნ.
46,83 მლნ.
56,47 მლნ.
Net profit margin
13,18%
9,29%
14,49%
15,71%
Earnings per share
-
-
-
-
Interest and investment income
4,30 მლნ.
4,95 მლნ.
4,19 მლნ.
4,60 მლნ.
Interest expense
-1,05 მლნ.
-1,18 მლნ.
-1,10 მლნ.
-1,00 მლნ.
Net interest expenses
3,25 მლნ.
3,78 მლნ.
3,10 მლნ.
3,60 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
98,11 მლნ.
8,47 მლნ.
80,20 მლნ.
73,76 მლნ.
Gain or loss from assets sale
330,57 ათ.
-3,90 მლნ.
-
-4,84 მლნ.
AI content may include mistakes. Learn more
Google აპები